comparemela.com
Home
Live Updates
Reveals Site Personnel - Breaking News
Pages:
Latest Breaking News On - Reveals site personnel - Page 1 : comparemela.com
Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
As Previously Announced, Reldesemtiv Had No Effect on the Primary Endpoint of Change from Baseline in ALSFRS-R or Key Secondary Endpoints Trial Discontinued…
Site personnel
Reldesemtiv had no effect
Primary endpoint
Key secondary
Futility following second planned interim
Reveals site personnel
Patients have favorable view
Trial features
Reduce burden
Reaking news
vimarsana © 2020. All Rights Reserved.